The UAMS COBRE Center for Studies of Host Response to Cancer Therapy is funding pilot projects aligned to understanding, predicting, and minimizing early and delayed adverse side effects of cancer treatment. The program targets basic and translational research projects and provides access to COBRE core facilities. Awardees are expected to engage in COBRE/IDeA meetings and provide progress reporting. The call explicitly prioritizes projects with a clear path to subsequent independent (ideally national) funding.
Eligibility Criteria:
- Applicant must hold a faculty position at UAMS or another academic institution in Arkansas.
- Proposed research should focus strongly on acute or chronic side effects of cancer therapy (mechanisms, socioeconomic impacts, prediction/mitigation strategies, etc.).
- Application should indicate a clear path to subsequent independent follow‑up funding.
Funding Details:
- Up to $100,000 direct costs for 1 year.
- Access to Center core facilities free of charge (Bioanalytical Core; Radiation and Imaging Core).
- Budget limits/restrictions include: no PI/key personnel salary; no subcontracts; no patient care costs; travel only for COBRE/IDeA meetings.
Deadline:
- Applications due: March 15, 2026 (by midnight).
- Anticipated project period: July 1, 2026 – June 30, 2027.
Where to go for further information:
- Submit via email to: mboerma@uams.edu (cc AALavender@uams.edu).
- Scientific/program contact: Marjan Boerma, PhD — mboerma@uams.edu.
- Program details.